Cytokinetics stock forecast

Author: fjfa

August undefined, 2024

WebMar 20, 2024 · The latest price target for . Cytokinetics (NASDAQ: CYTK) was reported by JP Morgan on March 20, 2024.The analyst firm set a price target for $52.00 expecting CYTK to rise to within 12 months (a ... WebGet the latest Cytokinetics, Inc. (CYTK) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.

Estimating The Fair Value Of Cytokinetics, Incorporated …

WebMar 3, 2024 · Shareholders in Cytokinetics, Incorporated (NASDAQ:CYTK) may be thrilled to learn that the analysts have just delivered a major upgrade to their near-term forecasts.The analysts have sharply ... WebApr 9, 2024 · Shares of CYTK stock opened at $36.42 on Friday. The stock has a fifty day moving average price of $39.79 and a 200 day moving average price of $42.22. The stock has a market cap of $3.48 billion ... canned energy tea

Where will Cytokinetics Stock Be In 1 Year? – Financhill

WebClose price at the end of the last trading day (Wednesday, 1st Mar 2024) of the CYTK stock was $43.11. This is 0.577% less than the trading day before Tuesday, 28th Feb 2024. During the day the stock fluctuated 2.40% from a day low at $42.86 to a day high of $43.89. WebApr 10, 2024 · Virtual Stock Exchange; Video. MarketWatch 25 Years; SectorWatch; ... Spinal Muscular Atrophy Medicine Market Size And Forecast. ... Roche acquired Cytokinetics, Inc.'s SMA program, which is a ... WebMar 4, 2024 · The stock price has risen 7.7% to US$36.56 over the past week. ... So while a broad number of companies are forecast to grow, unfortunately Cytokinetics is expected to see its sales affected worse ... canned emoji

Cytokinetics (Nasdaq:CYTK) - Stock Price, News & Analysis

Cytokinetics, Incorporated (CYTK) - Stock Analysis

WebFind the latest Cytokinetics, Incorporated CYTK analyst stock forecast, price target, and recommendation trends with in-depth analysis from research reports. Date Range … WebCYTK Stock 12 Months Forecast $58.50 (66.24% Upside) Based on 13 Wall Street analysts offering 12 month price targets for Cytokinetics in the last 3 months. The … canned enchilada sauce reviewsWebApr 10, 2024 · It has been a rough year so far for late-stage biopharmaceutical company, Cytokinetics, Incorporated CYTK. Shares of the company have moved down 20.5% compared with the industry’s decline of 4.7%. canne de pirsch stable stick

"WebAug 8, 2024 · But note: Cytokinetics may not be the best stock to buy. So take a peek at this free list of interesting companies with past earnings growth (and further growth forecast). " - Cytokinetics stock forecast

Cytokinetics stock forecast

CYTK stock forecast for 2024 – 2027 - FORECST.COM

WebJan 2, 2024 · Cytokinetics gets plenty of support on Wall Street; Its Strong Buy consensus rating is based on 11 recent reviews that include 10 Buys over just 1 Hold. The shares are selling for $45.82 and their $63.18 … WebFeb 13, 2024 · Cytokinetics Stock Forecast and Price Target In recent months, two notable analysts have provided yearlong price targets for Cytokinetics, with the average …

Did you know?

WebMar 2, 2024 · Find out the current price target and stock forecast for Cytokinetics ... the average price target for Cytokinetics comes to $61.40. The forecasts range from a low of $47.00 to a high of $80.00 ... WebApr 5, 2024 · According to analysts' consensus price target of $56.21, Cytokinetics has a forecasted upside of 54.4% from its current price of $36.42. Amount of Analyst Coverage …

WebSOUTH SAN FRANCISCO, Calif., April 03, 2024 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that on March 31, 2024 it granted stock … WebCytokinetics is a late-stage biopharmaceutical company focused on discovering, developing, and commercializing muscle activators and inhibitors. Investors & Media Cytokinetics’ unparalleled expertise has kept it at the forefront of drug discovery and development for diseases impacting muscle performance.

WebApr 3, 2024 · Stock Price Forecast. According to 22 stock analysts, the average 12-month stock price forecast for CYTK stock is $ 63.44 , which predicts an increase of 70.72%. … WebMar 20, 2024 · Cytokinetics Stock (NASDAQ:CYTK), Analyst Ratings, Price Targets, Predictions. Analysts publish ratings and price targets on most stocks.

WebMar 7, 2024 · Future criteria checks 0/6. Cytokinetics, Incorporated's earnings is forecasted to decline at 23.5% and its revenue is expected to decline at 46.6%. Cytokinetics, Incorporated has a predicted EPS and ROE of 27.5% and -44.7% respectively.

WebApr 13, 2024 · The projected fair value for Cytokinetics is US$38.04 based on 2 Stage Free Cash Flow to Equity. Cytokinetics' US$34.05 share price indicates it is trading at similar levels as its fair value estimate fix my task schedulerWeb18 hours ago · Price To Free Cash Flow is a widely used stock evaluation measure. Find the latest Price To Free Cash Flow for Cytokinetics (CYTK) ... * Price Target & Stock Forecast ; Full Company Report ... fixmytearWebApr 2, 2024 · Posted by MarketBeat News on Apr 2nd, 2024. Shares of Cytokinetics, Incorporated ( NASDAQ:CYTK – Get Rating) gapped up before the market opened on Friday . The stock had previously closed at $34 ... canned entriesWebMar 20, 2024 · Cytokinetics, Incorporated (CYTK) share price prediction for 2024, 2024, 2025, 2026 and 2027. CYTK one year forecast. Cytokinetics stock monthly and weekly forecasts. fix my tax messWebApr 2, 2024 · In 2024, Cytokinetics reported revenues of $2.0 million for Q4 and $94.6 million for the full year, compared to $55.6 million and $70.4 million in the same periods … canne derby plianteWeb2 days ago · The Cytokinetics stock price fell by -3.54% on the last day (Wednesday, 12th Apr 2024) from $35.30 to $34.05. During the last trading day the stock fluctuated 5.99% … canned entryWebStock analysis for Cytokinetics Inc (CYTK:NASDAQ GS) including stock price, stock chart, company news, key statistics, fundamentals and company profile. fix my teeth cheap